Autoimmune Diseases

COVID-19 Versus Seasonal Influenza Outcomes in Autoimmune Disease Patients 

A recent multi-national study evaluated 30-day outcomes in hospitalized COVID-19 patients living with autoimmune disease (AD). Data was aggregated from centers including Columbia University Irving Medical Center and Information System for Research in Primary Care-Hospitalisation Linked Data in Spain. 133,589 patients diagnosed and 48,428 hospitalized with COVID-19 and living with autoimmune disease were included in the study.  

Read More »

Type 1 Diabetes Patients Become Eligible for COVID-19 Vaccine in 12+ States

The Colorado Department of Health along with 11 other states just raised vaccination eligibility requirements for type 1 diabetes patients as a “high risk” group. In Colorado, anyone between the ages of 16-64 who have T1 diabetes and one other high risk condition will be eligible to get the coronavirus vaccine as early as today, March 5. They will be included in the 1B.3 vaccine group. This comes after Juvenile Diabetes Research Foundation’s (JDRF) extensive lobbying efforts to list T1 diabetes as a high risk condition alongside T2 diabetes.

Read More »

Autoimmune Diseases Reported to be Triggered by SARS-CoV-2

The group at the Zabludowicz Center for Autoimmune Diseases of the Sheba Medical Center and the Laboratory of the Mosaic of Autoimmunity at Saint Petersburg State University have comprehensively investigated and reported the association between various common pathogenic viruses and the development of autoimmune and chronic inflammatory diseases. In light of the current global pandemic, they have also shifted their focus to include a recent (December 2020) review of the appearance of autoimmune diseases reported to be triggered by a SARS-CoV-2 infection.

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.